United States Posaconazole Market Report 2017

In this report, the United States Posaconazole market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Posaconazole in these regions, from 2012 to 2022 (forecast).

United States Posaconazole market competition by top manufacturers/players, with Posaconazole sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Merck Sharp Dohme

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Delayed-release Tablets
Oral Suspension
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Posaconazole for each application, including
Prophylaxis of Invasive Aspergillus and Candida Infections
Oropharyngeal Candidiasis(OPC)
Invasive Infections by Candida, Mucor, and Aspergillus Species
Chronic and Acute Chagas Disease